AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75F40123C00079MCNEAL PROFESSIONAL SERVICES, INC.
Overview
Award facts
- Net obligations
- $3.20M
- $3,199,585of $3.20M potential value
- Outlays (paid to date)
- $2.44M
- $2.44M paid of $3.20M obligated$2,444,179
- Period of performance
- Jul 17, 2023 to Jul 16, 2025
- Ended
- Modifications
- 4
- Latest action Sep 10, 2025
- Contract type
- Definitive contract
- PIID 75F40123C00079
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
CONTRACT WILL PROVIDE SUPPORT TO THE CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), OFFICE OF VACCINES RESEARCH AND REVIEW IN PERFORMING MISSION-CRITICAL RESEARCH TO SUPPORT VACCINE SAFETY AND EFFICACY.
Dates and value
- Award date
- Signed on Jul 17, 2023
- Potential end of performance
- Jul 15, 2025
- Current value
- $3,199,585Base and exercised options
- Potential value (if all options are exercised)
- $3,199,585
Obligations by fiscal year of action
- FY2024: $1,571,518
- FY2023: $1,628,067
Total across 2 fiscal years: $3,199,585
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 10, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationKENNESAW, GA
UEICE9HAPWCZL58
CAGE code1YA88
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyMCNEAL PROFESSIONAL SERVICES INC.
Business types and certifications
Women-ownedWomen-owned small business (WOSB)Self-certified small disadvantaged businessFor-profit organizationSubchapter S corporationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Cures activities; National center for toxicological research; Fda other activities (fda headquaters); Cooperative research and development (CRADA); Biologics; Coronavirus emergency funding supplemental; Fda reimbursable program (federal sources)Program activities075-0600, 075-5148, 075-5629Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Kennesaw, Cobb County, Georgia 30144-3605
- Congressional district (place of performance)
- GA-11As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R499SUPPORT- PROFESSIONAL: OTHER (service)
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- Women owned small business sole sourceWOSBSS
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- 75F40123Q00304(as reported)
- Solicitation date
- Jun 21, 2023
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jul 17, 2023Base obligation at award: $1,628,067
- Latest action
- Sep 10, 2025 — Other administrative actionModification P00004; administrative: no change in scope or value
- Latest substantive action
- Apr 15, 2025 — Terminated for convenienceModification P00003
- Actions by type
- Base award1
- Supplemental agreement (within scope)1
- Terminated for convenience1
- Option exercised1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- Yes
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2023/2023-0600-000
- 075-2024/2024-0600-000
- 075-X-0600-000
- 075-X-5148-000
- 075-X-5629-000
- Object classes
- 25.2: Other services from non-Federal sources
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- N: Emergency P.L. 116-136
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $250,000
- COVID-19 supplemental outlays
- $209,511